. The safety of infliximab infusions in the community setting. Can J Gastroenterol2010;24:307–11.

In this study, Ducharme and colleagues report on the experience in community infusion centres with patients using infliximab
for a variety of indications. As the authors state, randomised clinical trials are not the ideal environment to assess safety,12 and ‘real-world’ experience after the drugs are available to use give us a more complete picture for both the efficacy and
the safety of any medication. This is a commendable effort that will provide important information for practitioners and patients
alike.

In this retrospective chart review study, all infusions over 18 months in selected clinics in Ontario were reviewed. These
centres had protocols in place, as they should, for recording the incident and …